Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Carnival Corp. (CCL): Expect Positive 2019 Outlook On Earnings Call - Nomura
-
Sarepta Therapeutics (SRPT) and Pfizer (PFE) Could Make Headlines At The World Muscle Society Conference - Nomura
-
After Albayrak's economy program, investor concern turns to Turkey's banks
-
Skyworks Solutions (SWKS) Has Solid Positioning in iPhone XS/XS Max - Nomura
-
Qorvo (QRVO) Content Hidden on iPhone XS/XS Max - Nomura
-
KKR-backed Calsonic lines up 5 billion euro financing for Magneti takeover: sources
-
Micron Technology (MU) PT Lowered to $65 at Nomura/Instinet
-
Alnylam Pharma's (ALNY) Cardiac Paper Falls Short, Reit Reduce - Nomura
-
Nomura Cuts Red Hat (RHT) PT But Believes Bookings Indicate An Uptick Is Coming
-
Criteo (CRTO) Could See Positive Inflection in C1H19 - Nomura
-
Argenx (ARGX) Weakness Is Unfounded, Reiterated Buy - Instinet
-
Form 6-K NOMURA HOLDINGS INC For: Sep 20
-
Economic growth expected to slow significantly in 2019; Chief U.S. Economist Ellen Zentner of Morgan Stanley wins Lawrence R. Klein Award for forecasting accuracy
-
Micron Technology (MU) on Watch as Samsung Electronics Postpones DRAM Capex Again
-
Pre-Open Movers 09/19: (MTEM) (TLRY) (NBEV) Higher; (GTHX) (NOK) (EVOP) Lower (more...)
-
Exelixis (EXEL) Partner Ipsen Reports Health Canada’s Approval of CABOMETYX (cabozantinib) Tablets
-
Exelixis’ Partner Ipsen Announces Health Canada’s Approval of CABOMETYX® (cabozantinib) Tablets for the Treatment of Adults with Previously Treated Advanced Renal Cell Carcinoma
-
Exelixis’ Partner Ipsen Announces Health Canada’s Approval of CABOMETYX® (cabozantinib) Tablets for the Treatment of Adults with Previously Treated Advanced Renal Cell Carcinoma
-
Nomura/Instinet Upgrades Juniper Networks (JNPR) to Buy
-
Command Security (MOC) to be Acquired by Prosegur for $2.85 Per Share
-
Command Security Corporation Announces Signing of Definitive Acquisition Agreement With Prosegur for $2.85 Per Share
-
Nomura Cuts Oracle (ORCL) PT To $58
-
Robert Half (RHI) PT Raised to $86 at Nomura/Instinet
-
Amazon (AMZN) Rolls Out Store Fronts And Becomes A Virtual Landlord - Nomura
-
Nomura/Instinet Downgrades Playa Hotels & Resorts (PLYA) to Neutral
-
Orchid Island Capital Announces September 2018 Monthly Dividend and August 31, 2018 RMBS Portfolio Characteristics
-
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
-
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
-
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
-
Nomura/Instinet Estimates Typhoon Impact ~500bps to Sept. Macau GGR
-
iCAN: Israel Cannabis Secures Additional Funding Round With an Oversubscribed CLA and Announces Formation of New Board of Directors
-
Apple's (AAPL) First Weekend Of New iPhone Sales Shows Few Surprises - Nomura
-
Nomura/Instinet Upgrades Broadcom Limited (AVGO) to Buy
-
Trends Are Strong in Macau Despite Stock Sell-Offs - Nomura (MLCO) (MGM) (WYNN) (LVS)
-
Nomura/Instinet Resumes Yahoo Japan (YAHOF) at Buy
-
China data shows pressure building on economy despite output surprise
-
Bragar Eagel & Squire, P.C. is Investigating Alnylam Pharmaceuticals, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm
-
Fannie Mae Announces the Results of its Eighth Reperforming Loan Sale Transaction
-
Venator Materials (VNTR) PT Lowered to $12 at Nomura/Instinet
-
Galapagos NV (GLPG) Prices 2.575M ADS Offering at $116.50/ADS
-
Galapagos raises $300 million gross proceeds in a U.S. public offering
-
Galapagos raises $300 million gross proceeds in a U.S. public offering
-
Galapagos raises $300 million gross proceeds in a U.S. public offering
-
Alnylam (ALNY) Lower as Nomura Highlights ONPATTRO Cardiac Concerns in New FDA Doc
-
Nomura Cuts Ctrip.com (CTRP) To $49 From $52 On Currency Driving Travel Weaknss
-
Nomura/Instinet Downgrades Sumco (SUOPY) to Neutral
-
Mueller Water Products (MWA) PT Lowered to $14 at Nomura/Instinet
-
Finisar (FNSR), Lumentum (LITE) Weaker on Nomura microwave ToF Comments
-
Natixis appoints Benito Berber as Chief Economist for Latin America
-
Tesla (TSLA) call put ratio 1 to 1 as shares sell off 2.4% on downgrade

